Nuvectis Pharma Inc Sustainability Reports
Nuvectis Pharma, Inc. is a clinical-stage biopharmaceutical company focused on the development of innovative targeted therapies for serious conditions in oncology and complement-related diseases. The company's pipeline includes precision medicine drug candidates such as NXP800 and NXP900 designed to inhibit difficult-to-drug cancer pathways.
Sector: Manufacturing
Country: United States
Exchange: Nasdaq
FIGI: BBG012BCR158
1 reports from 2021 to 2021
Company Profile
Nuvectis Pharma, Inc. is a clinical-stage biopharmaceutical company focused on the development of innovative targeted therapies for serious conditions in oncology and complement-related diseases. The company's pipeline includes precision medicine drug candidates such as NXP800 and NXP900 designed to inhibit difficult-to-drug cancer pathways.
Reports
1 total
Limited sustainability disclosure available
This company only publishes Annual Reports without dedicated sustainability sections.
Years
